Kutatási jelek – Signal Engine

• Head and Neck Cancer — Head and neck squamous cell carcinoma
• The Evolution and Future Directions of Targeted Therapy for Advanced G — Gastrointestinal stromal tumor
• Five‑year follow‑up of OPTIC: long‑term efficacy, safety, and mutation analyses of ponatinib in chronic‑phase chronic myeloid leukemia from a randomized phase 2 trial — Chronic myeloid leukemia
• Long-term Follow-up of Patients with Intermediate-risk Neuroblastoma Treated with Response- and Biology-Based Therapy: A Report From the Children’s Oncology Group Study ANBL0531 — Neuroblastoma
• Self‑collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline — Cervical cancer
• Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition — Merkel cell carcinoma
• Clinical Trials for Mesothelioma Treatment: What to Expect — Malignant pleural mesothelioma
• Six-year results of the CLL14 study — redefining long-term outcomes in chronic lymphocytic leukemia management — Chronic lymphocytic leukemia
• MDM2 degraders for Merkel cell carcinoma: round peg in a round hole — Merkel cell carcinoma
• The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non‑JAK Inhibitor Therapies — Myelofibrosis
• Waldenstrom's Macroglobulinemia Clinical Trials and Research | Dana‑Farber Cancer Institute — Waldenstrom macroglobulinemia
• Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia — Waldenstrom macroglobulinemia
• First-line treatment options for advanced leiomyosarcoma evaluated by propensity‑score matching — Leiomyosarcoma
• Future Directions in the Treatment of Osteosarcoma — Osteosarcoma
• Asciminib in Newly Diagnosed Chronic Myeloid Leukemia — Chronic myeloid leukemia
• Completed Studies – Adenoid Cystic Carcinoma Research Foundation — Adenoid cystic carcinoma
• Observational Retrospective Study of the Treatment of Waldenström's Macroglobulinemia with Ibrutinib in Routine Clinical Practice in Spain — Multiple myeloma
• Targeted therapy for advanced renal cell carcinoma — Renal cell carcinoma
• Top advances of the year: Melanoma — Melanoma
• MAPK Signaling and the Tumor Microenvironment: Drivers of Cancer Development and Resistance — NSCLC